Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis.
Leishmania donovani causes visceral leishmaniasis (VL), which is typically fatal without treatment. There is substantial variation between individuals in rates of disease progression, response to treatment and incidence of post-treatment sequelae, specifically post-kala-azar dermal leishmaniasis (PK...
Main Authors: | Michael D Lewis, Andrea Paun, Audrey Romano, Harry Langston, Charlotte A Langner, Ian N Moore, Kevin W Bock, Amanda Fortes Francisco, Jason M Brenchley, David L Sacks |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-04-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1008456 |
Similar Items
-
Non-Leishmania Parasite in Fatal Visceral Leishmaniasis–Like Disease, Brazil
by: Sandra R. Maruyama, et al.
Published: (2019-11-01) -
Non-Leishmania Parasite in Fatal Visceral Leishmaniasis–like Disease, Brazil
by: Malgorzata Anna Domagalska, et al.
Published: (2020-02-01) -
Fatal Visceral Leishmaniasis Caused by Leishmania infantum, Lebanon
by: Rana El Hajj, et al.
Published: (2018-05-01) -
Parasite and host determinants of visceral leishmaniasis
by: McCall, Laura-Isobel
Published: (2013) -
Skin parasite landscape determines host infectiousness in visceral leishmaniasis
by: Johannes S. P. Doehl, et al.
Published: (2017-07-01)